Chandan K. Sen

[2] At the University of Pittsburgh, Professor Sen serves as Associate Vice Chancellor for Life Sciences Innovation and Commercialization.

[12] His work has included the study of the electroceutical management of infection, and tocotrienol form on natural vitamin E. Sen has an H-index of 116.

In January 1995, Sen went to the University of California Berkeley for his postdoctoral studies on redox signaling in the Molecular and Cell Biology department (1995-1996).

[15] He was the founding Executive Director of the OSU Comprehensive Wound Center, and the founding Director of the OSU Center for Regenerative Medicine & Cell-Based Therapies[16] While at Ohio State, his primary areas of research interest included tissue injury, repair, regeneration, and infection that he studied through his research in stroke, tissue reprogramming, and cutaneous wound healing.

[19] Sen’s work has also led to electroceutical management of tissue infection, which received the Frost & Sullivan award for new product innovation.

[20] In 2018 Sen was called “one of the world’s leading experts in the nascent field of regenerative medicine” by the Indianapolis Business Journal after he joined Indiana University as the Director of Indiana Center for Regenerative Medicine and Engineering (ICRME), Executive Director of IU Health Comprehensive Wound Center, J. Stanley Battersby Chair and Professor of Surgery, Associate Vice President of Research, Associate Dean for Entrepreneurial Research.

[23] During the 2020 pandemic, Sen’s work discovered that electrical field can inactive coronavirus and that such approach can be used to develop person protective equipment employing an electroceutical fabric.